###begin article-title 0
###xml 22 27 <span type="species:ncbi:10090">Mouse</span>
Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia
###end article-title 0
###begin p 1
Conceived and designed the experiments: JC BOW BTT. Performed the experiments: JC KF DP PW JK YL DH. Analyzed the data: JC JP CNQ KD RZ XJY KAF BTT. Contributed reagents/materials/analysis tools: SKK PZ BC. Wrote the paper: JC SKK BTT.
###end p 1
###begin p 2
###xml 85 88 85 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 181 184 181 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 383 390 383 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ksp-Cre</italic>
###xml 449 452 449 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 478 487 478 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 475 495 475 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/Ksp-Cre</italic>
###xml 627 636 627 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 624 644 624 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/Ksp-Cre</italic>
###xml 779 785 779 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 775 793 775 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD <sup>flox/+</sup>/Ksp-Cre</italic>
###xml 906 909 906 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1231 1234 1231 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 462 467 <span type="species:ncbi:10090">mouse</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
The Birt-Hogg-Dube (BHD) disease is a genetic cancer syndrome. The responsible gene, BHD, has been identified by positional cloning and thought to be a novel tumor suppressor gene. BHD mutations cause many types of diseases including renal cell carcinomas, fibrofolliculomas, spontaneous pneumothorax, lung cysts, and colonic polyps/cancers. By combining Gateway Technology with the Ksp-Cre gene knockout system, we have developed a kidney-specific BHD knockout mouse model. BHDflox/flox/Ksp-Cre mice developed enlarged kidneys characterized by polycystic kidneys, hyperplasia, and cystic renal cell carcinoma. The affected BHDflox/flox/Ksp-Cre mice died of renal failure at approximate three weeks of age, having blood urea nitrogen levels over tenfold higher than those of BHD flox/+/Ksp-Cre and wild-type littermate controls. We further demonstrated that these phenotypes were caused by inactivation of BHD and subsequent activation of the mTOR pathway. Application of rapamycin, which inhibits mTOR activity, to the affected mice led to extended survival and inhibited further progression of cystogenesis. These results provide a correlation of kidney-targeted gene inactivation with renal carcinoma, and they suggest that the BHD product FLCN, functioning as a cyst and tumor suppressor, like other hamartoma syndrome-related proteins such as PTEN, LKB1, and TSC1/2, is a component of the mTOR pathway, constituting a novel FLCN-mTOR signaling branch that regulates cell growth/proliferation.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 194 197 194 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Birt1">[1]</xref>
###xml 246 249 246 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Welsch1">[2]</xref>
###xml 251 254 251 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Lindor1">[3]</xref>
###xml 260 263 260 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 489 492 489 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Khoo1">[4]</xref>
###xml 494 497 494 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Nickerson1">[5]</xref>
###xml 499 502 499 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Schmidt1">[6]</xref>
###xml 558 561 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 670 673 670 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 724 727 724 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Schmidt2">[7]</xref>
###xml 729 732 729 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Vocke1">[8]</xref>
###xml 734 737 734 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Warren1">[9]</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Khoo2">[10]</xref>
###xml 784 787 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Lingaas1">[11]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Okimoto1">[12]</xref>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Okimoto2">[13]</xref>
###xml 238 246 <span type="species:ncbi:9606">patients</span>
###xml 589 597 <span type="species:ncbi:9606">patients</span>
###xml 817 821 <span type="species:ncbi:9615">dogs</span>
###xml 826 830 <span type="species:ncbi:10116">rats</span>
Birt-Hogg-Dube (BHD) syndrome is an autosomal dominant genetic disease characterized by fibrofolliculomas (follicular hamartomas), renal cell carcinomas, spontaneous pneumothorax, and lung cysts[1]. Renal cysts were also observed in some patients[2], [3]. The BHD gene (accession number, BC015687), located on chromosome 17p11.2, contains 14 exons spanning approximately 20 kb of genomic DNA and encodes a protein of 579 amino acids, folliculin (FLCN) that has no known functional domains [4], [5], [6]. Germ-line mutations, somatic alterations, and loss of BHD mRNA have been observed in patients with BHD, colorectal cancer, and in some cases of gastric cancer; thus, BHD may be viewed as a candidate tumor-suppressor gene[7], [8], [9], [10]. Germ-line mutations of the counterpart BHD have also been identified in dogs and rats having renal cell carcinomas and renal multiple cysts [11], [12], [13].
###end p 4
###begin p 5
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LKB1</italic>
###xml 288 297 288 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC1/TSC2</italic>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Liaw1">[14]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Marsh1">[15]</xref>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Toro1">[16]</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Inoki1">[17]</xref>
###xml 467 470 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Baba1">[18]</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-vanSlegtenhorst1">[19]</xref>
###xml 907 917 907 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 975 979 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Singh1">[20]</xref>
###xml 984 992 984 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1106 1110 1106 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Baba1">[18]</xref>
###xml 1231 1235 1231 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-vanSlegtenhorst1">[19]</xref>
###xml 907 917 <span type="species:ncbi:7227">Drosophila</span>
###xml 1123 1136 <span type="species:ncbi:4896">fission yeast</span>
As one of the hamartoma syndromes, BHD shares many clinical features (such as follicular hamartomas, mucosal fibromas, and internal malignancy) with Cowden syndrome (CD, affected gene PTEN), Peutz-Jeghers syndrome (PJS, affected gene LKB1), and tuberous sclerosis complex (affected genes TSC1/TSC2) [14], [15], [16]. Of these, Cowden syndrome shares the most clinical features with BHD. While PTEN, LKB1, and TSC1/2 are critical members of the mTOR pathway [17], the BHD protein FLCN has also been suggested to be involved [18], [19]. These findings imply that FLCN, like PTEN, may also be a pivotal tumor suppressor gene and a potential player in mTOR pathway. Over the last few years, interest in FLCN has grown significantly. A few model organisms have been used to explore the physiological role of FLCN. However, these studies presented discrepant results, which leave the function of FLCN elusive. In Drosophila, the Bhd homologue was linked to JAK-STAT and Dpp pathway[20]. An in vitro experiment revealed that FLCN interacts with AMPK in mammalian cell lines, associating FLCN with the mTOR pathway[18], whereas in fission yeast, Bhd was reported to activate the mTOR counterpart Tor2, presenting an opposite role to Tsc1/2[19].
###end p 5
###begin p 6
###xml 9 17 9 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 135 138 135 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 194 205 194 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD in vivo</italic>
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 354 357 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 779 782 779 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Baba2">[21]</xref>
###xml 891 894 891 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1108 1111 1108 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 108 114 <span type="species:ncbi:9606">humans</span>
###xml 667 672 <span type="species:ncbi:10090">mouse</span>
###xml 836 841 <span type="species:ncbi:10090">mouse</span>
###xml 1014 1022 <span type="species:ncbi:9606">patients</span>
###xml 1119 1124 <span type="species:ncbi:10090">mouse</span>
Since no in vitro experiments or nonmammalian model can replicate the complex processes of tumorigenesis in humans, the development of BHD-deficient animal models will shed light on the role of BHD in vivo and on the BHD-related biochemical pathways responsible for neoplasia, which eventually could lead to the development of therapeutic agents against BHD-related diseases. Although natural mutants could be used for experimental models, the possibilities of homozygous embryonic lethality and additional unknown genetic changes often impede further analysis of the phenotypes and the physiological role of the gene. The genetically engineered conditional knockout mouse model can bypass this barrier and provide a "cleaner" and more versatile system for functional studies of BHD gene protein FLCN. While it might be a suppressor of mouse cystogenesis demonstrated by a recent study[21], BHD is expected to be a potential tumor suppressor gene whose mutations have led to renal tumors and other diseases in BHD patients. Therefore, it is essential to further elucidate whether kidney-specific knockout of BHD in the mouse is also implicated in kidney tumorigenesis, and what mechanism is involved.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Generation of BHD conditional knockout construct and mice
###end title 8
###begin p 9
###xml 78 81 78 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</bold>
###xml 169 172 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 205 214 203 212 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 205 214 203 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g001"><bold>Figure 1A</bold></xref>
###xml 456 467 454 465 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B&#8211;E</bold>
###xml 456 467 454 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g001"><bold>Figure 1B&#8211;E</bold></xref>
###xml 532 535 530 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 662 668 660 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 659 668 657 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/+</sup></italic>
###xml 743 752 741 750 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 743 752 741 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g001"><bold>Figure 1C</bold></xref>
###xml 643 647 <span type="species:ncbi:10090">mice</span>
To generate a conditional knockout construct, we adopted the MultiSite Gateway(R) Three-Fragment Vector Construction system (Invitrogen, Carlsbad, CA) to inactivate the BHD gene by deleting exons 3 and 4 (Figure 1A). The construct was electroporated into 129/Sv strain embryonic stem (ES) cells. Correctly targeted ES cell clones were obtained after being selected with G418, screened by long-range PCR, and confirmed using PCR and Southern blot analysis (Figure 1B-E). For the generation of chimeras, ES cells heterozygous for the BHD-floxed allele were injected into C57BL/6 blastocysts by standard procedures. Chimeras were bred to C57BL/6 mice to produce BHDflox/+ heterozygotes, and germ-line offspring were identified by PCR genotyping (Figure 1C).
###end p 9
###begin title 10
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Targeting strategy and generation of BHD conditional knockout mice.
###end title 10
###begin p 11
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxp</italic>
###xml 297 300 297 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 308 311 308 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 414 417 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 465 497 465 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pENTR3C-loxPMCS-loxP-FRT-neo-FRT</italic>
###xml 510 513 510 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 519 522 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 544 563 544 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD-exon3-4-pENTR3C</italic>
###xml 681 694 681 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD-pDESTR4R3</italic>
###xml 878 883 <span type="species:ncbi:10090">mouse</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
(A) Construction of the BHD gene targeting vector using a combination of the Gateway and loxp systems. A 3.5-kb 5' homology arm containing exon 2 and a 3.0-kb 3' arm carrying exons 5 and 6 were integrated into the pDONR P4-P1R and pDONR P2R-P through a BP (attB and attP) reaction to generate the BHD-5' and BHD-3' homology entry clones, respectively. A 1.3-kb fragment of genomic DNA bearing exons 3 and 4 of the BHD gene was inserted to the modified pDONR vector pENTR3C-loxPMCS-loxP-FRT-neo-FRT between the SalI and NotI sites to generate a BHD-exon3-4-pENTR3C entry clone. The three entry clones, in combination with the modified destination vector, were incubated to create a BHD-pDESTR4R3 targeting construct through BP recombination reaction. (B) Positive-targeting ES clones were selected by long-range PCR and confirmed by Southern blot analysis. (C) PCR genotyping of mouse offspring using tail DNA. (D, E) Knockout mice and normal controls were validated by Southern blot analysis.
###end p 11
###begin title 12
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
BHD null mice are embryonic lethal
###end title 12
###begin p 13
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 149 158 149 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 146 158 146 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup></italic>
###xml 169 176 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-Cre</italic>
###xml 268 271 268 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>+/&#8722;</sup></italic>
###xml 272 279 272 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-Cre</italic>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 467 470 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 117 122 <span type="species:ncbi:10090">mouse</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 169 172 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 272 275 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 588 593 <span type="species:ncbi:9606">human</span>
To determine whether ablation of BHD affected the viability of mice, we first generated a conventional BHD-deficient mouse model by intercrossing BHDflox/flox mice with CMV-Cre transgenic strains that express Cre recombinase in all tissues. While most heterozygous BHD+/-/CMV-Cre mice showed no obvious abnormalities at age of 18 months, the homozygous mutation was embryonic lethal and BHD-/- mutants died between 3.5 dpc and 8.5 dpc, underscoring the importance of BHD in development. Indeed, genes that are important in embryonic development are frequently found to be the culprits in human cancers.
###end p 13
###begin title 14
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bhd</italic>
Kidney-specific inactivation of bhd results in renal cysts
###end title 14
###begin p 15
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Pavlovich1">[22]</xref>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 238 247 238 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 235 247 235 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup></italic>
###xml 256 263 256 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ksp-Cre</italic>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Shao1">[23]</xref>
###xml 390 393 390 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 393 399 393 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 400 407 400 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ksp-Cre</italic>
###xml 495 504 495 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 492 513 492 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/ Ksp-Cre</italic>
###xml 606 612 606 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 603 612 603 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/+</sup></italic>
###xml 613 620 613 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ksp-Cre</italic>
###xml 656 667 656 667 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A,B</bold>
###xml 656 667 656 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g002"><bold>Figure 2A,B</bold></xref>
###xml 674 677 674 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 677 686 677 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 687 694 687 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ksp-Cre</italic>
###xml 843 852 843 852 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 843 852 843 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g002"><bold>Figure 2C</bold></xref>
###xml 953 956 953 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 986 995 986 995 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 986 995 986 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g002"><bold>Figure 2D</bold></xref>
###xml 1103 1106 1103 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKD</italic>
###xml 1114 1125 1114 1125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A,B</bold>
###xml 1114 1125 1114 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g003"><bold>Figure 3A,B</bold></xref>
###xml 1168 1177 1168 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 1165 1177 1165 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup></italic>
###xml 1178 1185 1178 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ksp-Cre</italic>
###xml 1530 1541 1530 1541 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C&#8211;F</bold>
###xml 1530 1541 1530 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g003"><bold>Figure 3C&#8211;F</bold></xref>
###xml 1736 1739 1736 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 264 279 <span type="species:ncbi:10090">transgenic mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
BHD patients have a strong predisposition to develop bilateral and multifocal renal tumors with a variety of histologies [22], implying an effect of BHD on kidney tumorigenesis. We thus generated a kidney-specific knockout by breeding BHDflox/flox mice to Ksp-Cre transgenic mice with expression of Cre-recombinase under the control of the kidney-specific cadherin promoter [23]. While the BHDflox/+/Ksp-Cre heterozygous mice showed a normal phenotype at the age of 18 months, the homozygous BHDflox/flox/ Ksp-Cre mice developed bilateral polycystic kidneys that were over tenfold heavier than those of BHDflox/+/Ksp-Cre and wild-type littermate controls (Figure 2A,B). The BHDflox/flox/Ksp-Cre mice died of kidney failure at the age of 3 weeks, having over 10 times higher levels of blood urea nitrogen (BUN) than normal littermate controls (Figure 2C). The considerably low levels of BHD mRNA detected by real time RT-PCR demonstrated inactivation of BHD in most of the kidney cells (Figure 2D). The appearance of the cysts here is similar to that found in polycystic kidney disease caused by mutated PKD genes (Figure 3A,B). Histopathological examination of the BHDflox/flox/Ksp-Cre kidneys revealed extremely dilated renal tubules that predominantly originated from collecting ducts due to high expression of Ksp-Cre recombinase. While some proximal tubules were highly or moderately dilated, most of the other proximal tubules remained relatively normal as a result of extremely low expression levels of Ksp-cre recombinase (Figure 3C-F). Atrophic, compressed glomeruli were also observed, and degeneration, necrosis, and haemorrhage were frequently observed in the late stages. These morphological changes suggest that homozygous BHD inactivation in the kidney may cause loss of growth control in tubular epithelial cells.
###end p 15
###begin title 16
###xml 17 26 17 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 14 34 14 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/Ksp-Cre</italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Phenotypes of BHDflox/flox/Ksp-Cre mice.
###end title 16
###begin p 17
###xml 7 16 7 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 4 24 4 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/Ksp-Cre</italic>
###xml 820 823 820 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 845 854 845 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 842 862 842 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/Ksp-Cre</italic>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
(A) BHDflox/flox/Ksp-Cre mice developed polycystic kidney and died at age of three weeks. The kidneys from heterozygotes were phenotypically normal, similar to the ones from wild-type mice. (B) The organs from the affected mice were normal except for the kidneys (10 days old). There was not much size difference between the normal control kidneys and the affected kidneys at birth. However, the difference became apparent after the age of 5 days. At age of 10 days, the polycystic kidneys were approximate 15 times larger than those from normal controls. (C) Biochemical analysis revealed that the conditional knockout mice died of kidney failure due to high level of blood urea nitrogen (BUN). The BUN level dramatically elevated 15 days after birth. Most of the mice died at the age of 21 days. (D) The mRNA level of BHD in the kidneys of BHDflox/flox/Ksp-Cre mice is significantly lower than that in wild-type kidneys. The heterozygote also shows lower mRNA expression relative to the wild type. m = month; d = day. f/f = flox/flox; f/+ = flox/+.
###end p 17
###begin title 18
###xml 27 36 27 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 24 44 24 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/Ksp-Cre</italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Inactivation of FLCN in BHDflox/flox/Ksp-Cre mice led to polycystic disease, hyperplasia, cystic renal cell RCC.
###end title 18
###begin p 19
###xml 194 197 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 758 761 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 786 795 786 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 783 803 783 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/Ksp-Cre</italic>
###xml 420 440 <span type="species:ncbi:3868">lotus tetragonolobus</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
(A,B) Deficiency of FLCN resulted in polycystic disease. (C, D) No FLCN expression was detected in cysts (enlarged tubules). However, FLCN was still expressed in relatively normal tubules where BHD was not deleted or completely eliminated by Ksp-Cre due to no or low Ksp-Cre expression in some proximal tubules. (E, F) Most of the relative normal tubules were proximal tubules stained by proximal tubule-specific marker lotus tetragonolobus lectin (LTL). Many of the proximal tubules remained relatively normal, though some proximal tubules were also enlarged (indicated by arrow. (G, H) Hyperplasia (indicated by arrow) was frequently observed in the cysts. (I, J) Cystic renal cell carcinomas were also one of the important consequences of kidney-targeted BHD gene inactivation in BHDflox/flox/Ksp-Cre mice, which is morphologically distinct from regular cysts showed in A and B. (K, L) FLCN is predominately expressed in proximal tubules, which was demonstrated by the proximal-specific marker LTL (M). FLCN expression is quite weak in distal tubules, which was marked by the distal-tubule-specific marker, Na-Cl-cotransporter (TSC) (N). Scale bar = 50 microm.
###end p 19
###begin title 20
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bhd</italic>
Kidney-specific inactivation of bhd produced renal cell carcinoma (RCC)
###end title 20
###begin p 21
###xml 31 40 31 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 28 49 28 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/ Ksp-cre</italic>
###xml 328 339 328 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3G&#8211;J</bold>
###xml 328 339 328 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g003"><bold>Figure 3G&#8211;J</bold></xref>
###xml 461 473 461 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3G, H</bold>
###xml 461 473 461 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g003"><bold>Figure 3G, H</bold></xref>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Feldberg1">[24]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Deshpande1">[25]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Yousef1">[26]</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Hartman1">[27]</xref>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Hartman2">[28]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Azoulay1">[29]</xref>
###xml 707 711 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Han1">[30]</xref>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Truong1">[31]</xref>
###xml 719 723 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Nassir1">[32]</xref>
###xml 1109 1121 1109 1121 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 3I,J</bold>
###xml 1109 1121 1109 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g003"><bold>Figures 3I,J</bold></xref>
###xml 1121 1126 1121 1126 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 1126 1128 1126 1128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S1</bold>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003581.s002"><bold>S1</bold></xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 735 740 <span type="species:ncbi:9606">human</span>
###xml 1461 1465 <span type="species:ncbi:10090">mice</span>
We further examined whether BHDflox/flox/ Ksp-cre mice develop renal carcinomas along with the cysts. We observed that kidneys from mice less than two weeks old predominately presented dilated tubules and cysts, whereas mice more than 18 days old also developed hyperplasia and renal cell carcinoma in their polycystic kidneys (Figure 3G-J). Hyperplastic areas frequently exhibited as multiple layers of epithelial cells along the inner surface of the tubules (Figure 3G, H). Renal cell carcinoma, which presents as cystic RCC, was frequently observed in the extremely enlarged kidneys. Cystic RCC was first described in 1986 and more cases have been reported since then [24], [25], [26], [27], [28], [29], [30], [31], [32]. Images of human cystic RCC are also available in the webpathology website (; ). The occurrence of cystic RCC in the general population is 4 to 10%, or 1 to 2% of all renal tumors. The cystic RCC does not present as a solid mass, but rather as a unilocular or multilocular cystic mass that is composed of cancer cells growing in the form of cysts that are distinct from regular cysts (Figures 3I,J and S1). While some of the tumor cells lined the septa, the others protruded into the cystic lumen. Most of the tumor cells were larger than the regular cystic cells. Binucleated cystic RCC cells were also observed. Many cystic spaces are filled with hemorrhage or proteinaceous fluid. No solid tumors were observed in any of the affected mice, which may be attributed to their short lifespan; three weeks might not be sufficient for solid tumor development.
###end p 21
###begin title 22
Deficiency of FLCN and subsequent activation of mTOR contributed to renal cysts and RCCs
###end title 22
###begin p 23
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 381 390 381 390 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2</bold>
###xml 381 390 381 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003581.s003"><bold>Figure S2</bold></xref>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LKB1</italic>
###xml 417 423 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC1/2</italic>
###xml 561 569 561 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Baba1">[18]</xref>
###xml 688 691 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
To elucidate the biochemical mechanisms of the cystogenesis and carcinogenesis related to inactivation of the BHD gene, we investigated the possible relevance of BHD to the mTOR signaling pathway for the following reasons: 1) our microarray analysis revealed that ectopic expression of the BHD gene product, FLCN, led to down-regulation of the AKT- related mTOR pathway signature (Figure S2); 2) BHD, PTEN, LKB1, and TSC1/2 are all hamartoma syndrome-related genes, and the roles of PTEN, LKB1, and TSC1/2 in the mTOR pathway have been well-established; and 3) in vitro experiments indicated that FLCN interacted with AMPK, a member of the mTOR pathway [18]. All these clues implied that BHD gene may play an important role in suppression of cystogenesis and tumorigenesis and that its inactivation could lead to the formation of renal cysts and RCC through the mTOR pathway.
###end p 23
###begin p 24
###xml 491 502 491 502 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3K&#8211;N</bold>
###xml 491 502 491 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g003"><bold>Figure 3K&#8211;N</bold></xref>
###xml 584 595 584 595 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C&#8211;F</bold>
###xml 584 595 584 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g003"><bold>Figure 3C&#8211;F</bold></xref>
###xml 738 747 738 747 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3F</bold>
###xml 738 747 738 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g003"><bold>Figure 3F</bold></xref>
###xml 891 902 891 902 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C,D</bold>
###xml 891 902 891 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g003"><bold>Figure 3C,D</bold></xref>
###xml 981 984 981 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 117 122 <span type="species:ncbi:10090">mouse</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 283 288 <span type="species:ncbi:10090">mouse</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
Before investigating the correlation of FLCN with mTOR pathway, we first examined the distribution of FLCN in normal mouse kidney and polycystic kidney. To do this, we designed and developed a human BHD monoclonal antibody that is compatible with immunohistochemical analysis in the mouse. While FLCN was predominantly expressed in the normal proximal tubules and collecting ducts in the cortex, obvious expression was rarely observed in the kidney distal tubules of mice at age of 3 weeks (Figure 3K-N). In the polycystic kidney, FLCN was only detected in relatively normal tubules (Figure 3C-F), which are mainly proximal tubules. A small number of proximal tubules were also enlarged due to moderate expression of Ksp-Cre recombinase (Figure 3F, arrow), which is different from the previous report where the proximal tubules are not involved. All the enlarged tubules were FLCN-negative (Figure 3C,D), indicating a correlation of the formation of cysts with inactivation of the BHD gene.
###end p 24
###begin p 25
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 222 233 222 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A&#8211;C</bold>
###xml 222 233 222 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g004"><bold>Figure 4A&#8211;C</bold></xref>
###xml 265 274 265 274 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 265 274 265 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g004"><bold>Figure 4B</bold></xref>
###xml 353 362 353 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 353 362 353 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g004"><bold>Figure 4D</bold></xref>
###xml 512 520 512 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Baba1">[18]</xref>
###xml 602 609 602 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 912 921 912 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 909 921 909 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup></italic>
###xml 922 929 922 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ksp-Cre</italic>
###xml 1446 1449 1446 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 1592 1599 1592 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
###xml 1123 1127 <span type="species:ncbi:10090">mice</span>
We then explored whether the inactivation of BHD resulted in the activation of mTOR in affected cysts and RCCs. Immunohistochemical analysis showed that mTOR was activated through phosphorylation in cysts and cystic RCCs (Figure 4A-C), which stained FLCN-negative (Figure 4B). We further examined the phosphorylation status of the downstream target S6 (Figure 4D). Phosphorylated S6 has been observed in some cysts and in cystic RCC. Although FLCN was reported to be a possible downstream effector of mTOR in an in vitro experiment[18], our data revealed that deficiency of FLCN activated mTOR pathway in vivo, suggesting mTOR might a downstream target of FLCN. To further elucidate the correlation of FLCN and mTOR, we applied the mTOR inhibitor rapamycin to affected mice to see whether we could inhibit or reverse the development of cysts. Rapamycin treatment significantly extended the survival period of BHDflox/flox/Ksp-Cre mice and inhibited the development of cysts relative to control mice; some mice survived more than 50 days. However, once the rapamycin treatment was stopped, cysts redeveloped rapidly and the mice died within 10 days. This result indicated that rapamycin can inhibit cystic cell growth, but cannot reverse the cystic kidney phenotype. We also tested a few other members of the mTOR pathway (e.g. AKT) through IHC; no significant changes were observed or inconsistent results were obtained following inactivation of BHD, implying a novel FLCN-mTOR pathway branch may exists. In addition, FLCN might be related to other signaling pathways. Obviously, the precise in vivo mode of action of FLCN merits more investigation.
###end p 25
###begin title 26
mTOR signaling pathway was activated in the cystic cells, cystic RCC cells.
###end title 26
###begin p 27
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
(A) Cystic RCC was stained by hematoxylin and eosin (H&E). (B) No FLCN expression was detected in cystic RCC, indicating deletion of the BHD gene. Phosphorylated mTOR (C) and phosphorylated S6 (D) staining was observed in the corresponding FLCN-deficient cells. Scale bar = 50 microm.
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 161 172 161 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3K&#8211;N</bold>
###xml 161 172 161 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003581-g003"><bold>Figure 3K&#8211;N</bold></xref>
###xml 294 297 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 759 763 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Baba2">[21]</xref>
###xml 765 769 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Gnarra1">[33]</xref>
###xml 771 775 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Pollard1">[34]</xref>
###xml 831 834 829 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 245 250 <span type="species:ncbi:10090">mouse</span>
###xml 305 310 <span type="species:ncbi:10090">mouse</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
In this study, we provide the first evidence that the BHD protein FLCN predominantly expresses in the proximal tubules and collecting ducts of the renal cortex (Figure 3K-N). By developing and subsequently analyzing the conditional BHD knockout mouse model, we demonstrate that the deletion of BHD in the mouse kidney leads to cystic renal cell carcinoma (cystic RCC) in addition to polycystic kidney and hyperplasia. The cystic RCC was only observed in the older affected mice (>/=20 days old). This implies that most of the polycystic kidneys would only present regular cysts and various extents of hyperplasia if the affected mice are sacrificed earlier. Thus, although some kidney-specific knockout animal models of RCC-related genes failed to develop RCC[21], [33], [34], our data provide a connection between kidney-specific BHD gene inactivation and renal carcinogenesis. This finding suggests that BHD may act as a suppressor for both cystogenesis and tumorigenesis.
###end p 29
###begin p 30
###xml 346 349 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
No solid kidney tumors were observed in any of the affected mice, which may be attributed to their short lifespan and mouse distinct genetic background. It is entirely possible that if the cysts had not caused kidney failure at age of three weeks, progression of these cystic RCC to solid tumors would have occurred. In addition, inactivation of BHD gene in the kidney causes a large proportion of tubules to form cysts. Once cystogenesis starts, fast-growing cysts become dominant and lead to highly cystic kidneys, kidney failure, and early death. Thus, lack of appropriate microenvironment might be another reason that the malignant/pre-malignant cells failed to form solid renal tumors, which is a more complicated and slower process.
###end p 30
###begin p 31
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Baba2">[21]</xref>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LKB1</italic>
###xml 469 478 469 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC1/TSC2</italic>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Liaw1">[14]</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Marsh1">[15]</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Toro1">[16]</xref>
###xml 600 603 600 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
Our results further demonstrated that deficiency of BHD product FLCN led to activation of mTOR pathway in cystic cells, supporting the recent report and consolidating that FLCN is involved in mTOR pathway and mTOR may be downstream target of FLCN[21]. Interestingly, BHD is a member of the hamartoma syndrome family that includes Cowden syndrome (CD, affected gene PTEN), Peutz-Jeghers syndrome (PJS, affected gene LKB1), and tuberous sclerosis complex (affected genes TSC1/TSC2) [14], [15], [16]. While PTEN, LKB1, and TSC1/2 have played pivotal roles in the mTOR pathway, our findings suggest that BHD protein FLCN, like other hamartoma syndrome-related proteins such as PTEN, LKB1, and TSC1/2, is an important component of the mTOR pathway, constituting a novel FLCN-mTOR signaling branch that regulates cell growth/proliferation, though FLCN may involve in other pathways.
###end p 31
###begin title 32
Materials and Methods
###end title 32
###begin title 33
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
Design and generation of BHD conditional knockout construct
###end title 33
###begin p 34
###xml 21 24 21 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</bold>
###xml 160 164 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003581-Wang1">[35]</xref>
###xml 607 610 605 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 688 695 686 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 758 762 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 777 780 775 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dra</italic>
###xml 851 893 849 891 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATAACTTCGTATAGCATACATTATACGAAGTTATTT-3&#8242;</named-content>
###xml 907 949 905 947 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAATAACTTCGTATAATGTATGCTATACGAAGTTAT-3&#8242;</named-content>
###xml 1069 1072 1067 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dra</italic>
The MultiSite Gateway(R) Three-Fragment Vector Construction system (Invitrogen, Carlsbad, CA) was modified for the purpose of fabricating recombination vectors [35]. Of the four vectors supplied in the system, the pDONR vectors, pDONR P4-P1R, and pDONR P2R-P3 were used to generate the 5' and 3' homology arm entry clones. Another vector, pENTR3C, was used to carry a targeted gene sequence of interest. To meet the gene targeting purpose, a 1.8-kb loxP-FRT-neo-FRT fragment excised from p-loxp-2FRTPGKneo (a gift of D. Gordon) was added to generate pENTR3CloxP-FRT-neo-FRT, which allowed later excision of BHD exons 3 and 4 and the neomycin-resistance gene by cre-mediated recombination in vivo. Synthetic oligonucleotides were used to insert an additional loxP site into the DraI site of the pENTR3C-loxPFRT- neo-FRT vector. Oligonucleotides loxPF (5'-ATAACTTCGTATAGCATACATTATACGAAGTTATTT-3') and loxPR1 (5'-AAATAACTTCGTATAATGTATGCTATACGAAGTTAT-3') (IDT, Coralville, IA) were phosphorylated with T4 polynucleotide kinase (Invitrogen), annealed, and inserted into the DraI-digested pENTR3C-loxP-FRTneo-FRT vector to generate pENTR3C-loxPMCS-loxP-FRT-neo-FRT.
###end p 34
###begin p 35
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ccdB</italic>
###xml 235 266 235 266 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCTCGAGCAGGAAACAGCTATGAC-3&#8242;</named-content>
###xml 271 302 271 302 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCTCGAGTAAAACGACGGCCAGTG-3&#8242;</named-content>
###xml 323 326 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 363 366 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
To enrich targeted ES cell clones, we inserted a TK-negative selection cassette downstream of the attR3 site in the destination vector. The attR4-ccdB-attR3 domain was amplified from the pDEST/R4-R3 vector using the following primers: 5'-GCCTCGAGCAGGAAACAGCTATGAC-3' and 5'-GCCTCGAGTAAAACGACGGCCAGTG-3'. After digestion by XhoI, this domain was inserted into the XhoI site of the pPGKneo/TK vector (a gift from T. Gridley).
###end p 35
###begin p 36
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 151 154 151 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfx</italic>
###xml 409 412 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 507 510 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 516 519 516 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
To generate a BHD gene targeting construct, a 3.5-kb 5' homology arm containing exon 2 and a 3.0-kb 3' arm carrying exons 5 and 6, PCR-amplified using Pfx polymerase (Invitrogen), were integrated into the pDONR P4-P1R and pDONR P2R-P through BP reaction (attB and attP sites) to generate the BHD-5' and BHD-3' homology entry clones, respectively. A 1.3-kb fragment of genomic DNA bearing exons 3 and 4 of the BHD gene was inserted into the modified pDONR vector pENTR3C-loxPMCS-loxP-FRT-neo-FRT between the SalI and NotI sites to generate a BHD-exon3-4-pENTR3C entry clone. Finally, the three entry clones, in combination with the modified destination vector, were incubated to create a BHD-pDESTR4R3 targeting construct through BP recombination reaction.
###end p 36
###begin title 37
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Identification of homologous recombinant ES cells and generation of kidney-specific knockout mice
###end title 37
###begin p 38
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sca</italic>
###xml 492 498 488 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 489 498 485 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/+</sup></italic>
###xml 720 726 716 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 717 726 713 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/+</sup></italic>
###xml 834 840 830 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 831 840 827 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/+</sup></italic>
###xml 920 924 916 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox</sup>
###xml 917 924 913 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox</sup></italic>
###xml 942 951 938 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 939 951 935 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup></italic>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 754 769 <span type="species:ncbi:10090">transgenic mice</span>
###xml 854 858 <span type="species:ncbi:10090">mice</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
The generated BHD-pDESTR4R3 targeting construct carries an ampicillin-resistant gene and a neomycin-resistant gene flanked by FRT sites. The construct was linearized with ScaI for electroporation into 129/sj strain ES cells. After selection with 500 microg/ml G418 (Invitrogen), 1,039 ES cell clones were isolated. The G418-positive ES clones were first screened by long-range PCR and then confirmed by Southern blot analysis. For the generation of chimeras, ES cells heterozygous for the BHDflox/+ allele were injected into C57BL/6 blastocysts by standard procedures. Chimeras were bred to C57BL/6 mice, and germline offspring were identified by PCR genotyping. To remove the neomycin gene flanked by two FTR sites, BHDflox/+ mice were crossed to FlpeR transgenic mice that express the site-specific recombinase FLP (FLPe). Then, BHDflox/+ heterozygous mice were intercrossed to give rise to mice homozygous for the BHDflox allele, i.e., BHDflox/flox mice.
###end p 38
###begin p 39
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 60 69 60 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 57 69 57 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup></italic>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 156 162 156 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 153 170 153 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/+</sup>/Ksp-Cre</italic>
###xml 187 193 187 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 184 201 184 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/+</sup>/Ksp-Cre</italic>
###xml 235 244 235 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 232 244 232 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup></italic>
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD</italic>
###xml 286 295 286 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 283 303 283 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/Ksp-Cre</italic>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 102 117 <span type="species:ncbi:10090">transgenic mice</span>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
To obtain mice with kidney-specific inactivation of BHD, BHDflox/flox mice were first bred to Ksp-Cre transgenic mice to generate BHD heterozygous mice (BHDflox/+/Ksp-Cre in kidneys). BHDflox/+/Ksp-Cre mice then were backcrossed to BHDflox/flox mice to generate BHD homozygous mice (BHDflox/flox/Ksp-Cre in kidneys).
###end p 39
###begin p 40
###xml 4 8 <span type="species:ncbi:10090">mice</span>
All mice were manipulated and housed according to protocols approved by the Institutional Animal Care and Use Committee (IACUC) of Van Andel Institute and conducted in an ethical, humane, and scientifically justified manner, and in full compliance with applicable regulations.
###end p 40
###begin title 41
Genotyping, RNA and protein analysis
###end title 41
###begin p 42
###xml 186 194 186 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003581.s001">Table S1</xref>
###xml 368 371 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xmn</italic>
###xml 377 380 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hin</italic>
ES cell DNA and tail DNA was extracted by using automated DNA isolation system (Kurabo Industries) and subjected to regular PCR and long-range PCR genotyping analysis (see supplementary Table S1 for PCR primers). For genotyping by Southern blot analysis, DNA from ES cells or tissues was extracted using standard DNA extraction procedure. Purified DNA was digested by Xmn I or Hind III, isolated by 0.8% agarose gel, and transferred onto nylon membrane. UV-linked or dried membranes were subjected to DNA hybridization with 5' or 3' probes.
###end p 42
###begin p 43
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Total RNA was isolated from various mouse tissues and cystic cell lines with Trizol reagent (Invitrogen) according to the manufacturer's instructions. Purified RNA was used for quantitative analysis (real-time RT-PCR) through ABI Prism 7700 Sequences Detector (Applied Biosystems).
###end p 43
###begin p 44
###xml 472 477 <span type="species:ncbi:10090">mouse</span>
For protein detection by Western blot, cultured cells and kidney whole-cell extracts prepared by homogenization were lysed in 1% Nonidet P-40, 50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, and 15% glycerol, plus standard protease inhibitors (protease inhibitor cocktail tablets, Roche Diagnostics). Equal amounts of mutant and control kidney cell protein extracts were size-separated by 10% SDS-PAGE and transferred to PVDF membranes (Invitrogen). FLCN was detected with a mouse monoclonal anti-FLCN antibody (developed by Laboratory of Antibody Technology) at a dilution of 1:750 using the enhanced chemiluminescence detection system.
###end p 44
###begin title 45
Immunohistochemistry and tubular marker staining
###end title 45
###begin p 46
###xml 143 149 <span type="species:ncbi:9986">Rabbit</span>
###xml 368 374 <span type="species:ncbi:9986">rabbit</span>
###xml 510 516 <span type="species:ncbi:3818">Peanut</span>
Immunohistochemical analysis was performed following the manufactory's protocols. The antibodies used include anti-FLCN mAb, anti-Phospho-mTOR Rabbit mAb (Cell Signaling), anti-Phospho-S6 Ribosomal Protein (Cell Signaling). Proximal tubules were stained by biotinylated Lotus Tetragonolobus Lectin (LTL, Vector Laboratories), and distal tubules were detected by using rabbit anti-thiazide-sensitive NaCl contransporter affinity purified polyclonal antibody (TSC, Chemicon) Tubular markers. Marker biotinylated Peanut Agglutinin (PNA, Vector Laboratories) was used to stain collecting ducts.
###end p 46
###begin title 47
Phenotyping and histopathology
###end title 47
###begin p 48
###xml 135 144 135 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 132 152 132 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/Ksp-Cre</italic>
###xml 323 324 323 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 255 260 <span type="species:ncbi:10090">Mouse</span>
Newborn mice were monitored daily. Sick mice were distinguished from healthy ones by enlarged abdomen at age of 10 days. Totally 73 BHDflox/flox/Ksp-Cre mice and 55 normal control littermates were collected for phenotyping and histopathological analysis. Mouse body weight, kidney weight were measured upon euthanasia by CO2 inhalation. Tissues including kidneys, lung, liver, spleen, heart, stomach, intestine, brain, testes were collected and fixed in 4% paraformaldehyde for 24 hours and kept in 70% ethanol for 12 hours before paraffin block preparation. Paraffin blocks were sectioned at 3 microm thick and stained with hematoxylin and eosin (H&E). Stained slides were evaluated by a board-certified veterinary pathologist B. Sigler and pathologists X. Yang and J. Peng.
###end p 48
###begin title 49
Blood biochemical analysis
###end title 49
###begin p 50
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse blood was collected by cardiac puncture at age of 5 days, 10 days, and 15 days, and 20 days. Serum was collected after centrifugation and stored at -80degreesC for further biochemical analysis.
###end p 50
###begin title 51
###xml 26 35 26 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 23 43 23 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/flox</sup>/Ksp-Cre</italic>
###xml 56 62 56 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 53 70 53 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHD<sup>flox/+</sup>/Ksp-Cre</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Rapamycin treatment of BHDflox/flox/Ksp-Cre mice and BHDflox/+/Ksp-Cre and wild-type control littermates
###end title 51
###begin p 52
###xml 814 815 804 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 100 104 <span type="species:ncbi:10090">Mice</span>
###xml 710 714 <span type="species:ncbi:10090">Mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
Totally 29 mice from three litters were used for rapamycin treatment (n = 15) and control (n = 14). Mice from each litter at postnatal 7 days were randomly divided into two groups of rapamycin treatment and control. Rapamycin (LC Laboratories, Woburn, MA) was dissolved in ethanol at a concentration of 20 mg/mL and stored at -20degreesC. The rapamycin solution was freshly prepared by diluting the rapamycin stock to 250 microg/ml in buffer (1:1 10% PEG-400, 8% ethanol:10% Tween 80) and were injected by intraperitoneally daily at a dose of 2.5 mg/kg body weight for the duration of the treatment. Control animals received i.p. injection of equal amount of vehicle (5% PEG-400, 4% ethanol, and 5% Tween 80). Mice were treated for at least two weeks starting at postnatal day 7. Moribund mice were subjected to CO2 euthanasia, dissection, and analysis in the duration of the treatment.
###end p 52
###begin title 53
Supporting Information
###end title 53
###begin p 54
Primer used for BHD knockout genotyping
###end p 54
###begin p 55
(0.02 MB XLS)
###end p 55
###begin p 56
Click here for additional data file.
###end p 56
###begin p 57
Additional cystic RCC samples stained by hematoxylin and eosin. Cystic spaces are filled with proteinaceous fluid (A-J) or hemorrhage (K,L) in cystic RCC. The tumor cells have clear cytoplasm and hyperchromatic nuclei lining the septa or growing into the cystic lumina. Scale bar = 50 microm.
###end p 57
###begin p 58
(5.38 MB TIF)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin p 60
Microarray analysis revealed that ectopic expression of FLCN led to down-regulation of the AKT- related mTOR pathway signature.
###end p 60
###begin p 61
(0.29 MB TIF)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 421 426 <span type="species:ncbi:10090">mouse</span>
We thank the following Van Andel Research Institute core facilities for their services: gene targeting core for generating the knockout; the vivarium for mouse husbandry; the sequencing core for nucleotide sequencing; the analytical, cellular, and molecular microscopy core for immunohistochemical analysis; and the flow cytometry core for blood analysis. In addition, we thank Dr. Bob Sigler for technical assistance in mouse pathology. We also thank David Nadziejka for technical editing and Sabrina Noyes for her administrative support.
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons.
###end article-title 65
###begin article-title 66
Birt-Hogg-Dube Syndrome.
###end article-title 66
###begin article-title 67
Birt-Hogg-Dube syndrome: an autosomal dominant disorder with predisposition to cancers of the kidney, fibrofolliculomas, and focal cutaneous mucinosis.
###end article-title 67
###begin article-title 68
Birt-Hogg-Dube syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2.
###end article-title 68
###begin article-title 69
###xml 110 118 <span type="species:ncbi:9606">patients</span>
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome.
###end article-title 69
###begin article-title 70
Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2.
###end article-title 70
###begin article-title 71
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome.
###end article-title 71
###begin article-title 72
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors.
###end article-title 72
###begin article-title 73
###xml 64 69 <span type="species:ncbi:9606">human</span>
Expression of Birt-Hogg-Dube gene mRNA in normal and neoplastic human tissues.
###end article-title 73
###begin article-title 74
Inactivation of BHD in sporadic renal tumors.
###end article-title 74
###begin article-title 75
###xml 151 154 <span type="species:ncbi:9615">dog</span>
A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog.
###end article-title 75
###begin article-title 76
###xml 29 32 <span type="species:ncbi:10116">rat</span>
Natural history of the Nihon rat model of BHD.
###end article-title 76
###begin article-title 77
###xml 79 82 <span type="species:ncbi:10116">rat</span>
A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer.
###end article-title 77
###begin article-title 78
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
###end article-title 78
###begin article-title 79
PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
###end article-title 79
###begin article-title 80
Exclusion of PTEN, CTNNB1, and PTCH as candidate genes for Birt-Hogg-Dube syndrome.
###end article-title 80
###begin article-title 81
###xml 41 46 <span type="species:ncbi:9606">human</span>
Dysregulation of the TSC-mTOR pathway in human disease.
###end article-title 81
###begin article-title 82
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
###end article-title 82
###begin article-title 83
###xml 108 133 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
The Birt-Hogg-Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe.
###end article-title 83
###begin article-title 84
###xml 4 14 <span type="species:ncbi:7227">Drosophila</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance.
###end article-title 84
###begin article-title 85
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.
###end article-title 85
###begin article-title 86
Renal tumors in the Birt-Hogg-Dube syndrome.
###end article-title 86
###begin article-title 87
Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract.
###end article-title 87
###begin article-title 88
Multilocular cystic renal cell carcinoma.
###end article-title 88
###begin article-title 89
Multilocular, predominantly cystic, renal cell carcinoma: an unusual gross appearance (a case report).
###end article-title 89
###begin article-title 90
Collecting duct carcinoma associated with oncocytoma.
###end article-title 90
###begin article-title 91
Cystic renal cell carcinoma: CT findings simulating a benign hyperdense cyst.
###end article-title 91
###begin article-title 92
Cystic renal cell carcinoma.
###end article-title 92
###begin article-title 93
Tubulocystic carcinoma of the kidney: a new entity among renal tumors.
###end article-title 93
###begin article-title 94
Cystic renal cell carcinoma: biology and clinical behavior.
###end article-title 94
###begin article-title 95
Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links.
###end article-title 95
###begin article-title 96
Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature.
###end article-title 96
###begin article-title 97
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice.
###end article-title 97
###begin article-title 98
Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway.
###end article-title 98
###begin article-title 99
###xml 101 105 <span type="species:ncbi:10090">Mice</span>
Simplified Method for the Construction of GeneTargeting Vectors for Conditional Gene Inactivation in Mice.
###end article-title 99
###begin p 100
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 100
###begin p 101
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: K.F. and S.K.K. were funded by the Japan Amway and the National Cancer Center postdoctoral fellowship grant, respectively. J.K. was supported by the Frederik and Lena Meijer student internship. This work was also supported by the Van Andel Foundation.
###end p 101

